Impact of Aerobic Exercise on Pain Modulation in Healthy Adults
Public ClinicalTrials.gov record NCT07083219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Aerobic Exercise and Pain Modulation: Examining the Impact on Pain Sensitivity in Healthy Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Exercise-Induced Hypoalgesia (EIH) refers to reduced pain sensitivity following exercise, particularly in response to noxious stimuli. Various exercise modalities, including isometric, aerobic, and resistance training, contribute to this effect. Pain experienced during exercise may activate descending inhibitory pathways, leading to subsequent pain relief. Conditioned Pain Modulation (CPM) is a behavioral measure of diffuse noxious inhibitory control (DNIC), where pain inhibits pain. It is proposed that pain within the exercising limb may serve as a conditioning stimulus, activating CPM. For instance, maximal handgrip exercise has been used to trigger CPM responses. In clinical settings, unpleasant physical therapy interventions like exercise, thermal modalities, and electrical stimulation may function through CPM mechanisms. CPM predicts EIH in both young and older adults, with painful exercise reducing pressure pain ratings across age groups. Isometric exercise has also been shown to decrease CPM in individuals with systemic EIH, suggesting shared mechanisms. Athletes exhibit higher pain thresholds and tolerance due to repeated exposure to high-intensity exercise. However, they demonstrate lower CPM activation, possibly as a compensatory response to chronic noxious input. This raises the question: Can repeated high-intensity aerobic exercise, perceived as painful, train the nervous system to enhance descending pain inhibition in non-athletes? While alterations in pain sensitivity related to analgesic-induced pain inhibition have been documented, the effects of continuous stimulation of central pain pathways via painful high intensity exercise, along with the mediating influence of psychosocial factors, remain underexplored. This study aims to investigate the central pain modulatory mechanisms (measured by QST) that have differential changes in participants who receive multiple sessions of high intensity aerobic exercise as an intervention compared to receiving single session. Additionally, the study will evaluate the impact of sociocultural factors, including optimism, pain catastrophizing, and marginalization on alterations in pain sensitivity.
Study identification
- NCT ID
- NCT07083219
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2025
- Primary completion
- Jun 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Dec 9, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Department of Physical Therapy and Movement Science, University of Texas at El Paso | El Paso | Texas | 79902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07083219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07083219 live on ClinicalTrials.gov.